Search bioRxivSearch

bioRxiv · 10.1101/696658

Phase discontinuities underlie increased drowsiness and diminished sleep quality in older humans

Abstract

Healthy humans switch seamlessly between activity states, wake up and fall asleep with regularity, and cycle through sleep stages necessary for restored homeostasis and memory consolidation each night. This study tested the hypothesis that such smooth behavioral transitions are accompanied by smooth transitions between stable neural states within the brain. A method for detecting phase discontinuities across a broad range of frequencies was created to quantify phase disruptions in the Fp-Cz EEG channel from 20 annotated sleep files. Phase discontinuities decreased with increasingly deep sleep, and increased phase discontinuity was associated with increased drowsiness, reduced deep sleep, and shorter REM sleep. A 10s phase discontinuity summary measure (the phase jump indicator) closely tracked the annotated sleep stages and enabled discrimination between short (< 10 min) and longer REM periods. Overall phase discontinuity correlated inversely with broadband EEG power, suggesting that reduced spurious signaling may facilitate increased synchronization. However, the correlation between phase discontinuity and power varied with sleep stage and age. Older individuals spent significantly more time in the Awake and Drowsy stages and less time in the deepest sleep stage and REM sleep. Interestingly, although EEG power was reduced in older individuals across all sleep stages, increased phase discontinuity only occurred in stages that showed impairment. In older patients the power vs. phase discontinuity correlation shifted to positive during drowsiness, suggesting potential deficits in cortical inhibition. These results provide evidence that phase discontinuity measures extend current capabilities for assessing sleep and may yield new insights into pathological brain states.\n\nSignificance statementEvidence continues to accumulate regarding the positive relationship between healthy sleep and brain function. Recent studies also show that more healthful sleep can be induced with timely application of non-invasive therapies. Accordingly, the ability to accurately assess sleep quality in real-time has become increasingly important. Here, a newly defined measure, referred to as phase discontinuity, enabled rapid identification of unhealthful neural patterns associated with increased drowsiness, reduced deep sleep, and early termination of REM sleep. Moreover, the measure was linked to underlying neuronal and circuit properties known to impact sleep quality. Thus, the phase discontinuity measure defined in this study provides new insight into sleep pathology and has potential implications for closed-loop therapeutic intervention.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Sanders, T. H.. 2019-07-09. Phase discontinuities underlie increased drowsiness and diminished sleep quality in older humans. https://doi.org/10.1101/696658

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience